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Abstract: HIV-1 M originated from SIVcpz endemic in chimpanzees from southeast 
Cameroon or neighboring areas, and it started to spread in the early 20th century. Here we 
examine the factors that may have contributed to simian-to-human transmission, local 
transmission between humans, and export to a city. The region had intense ape hunting, 
social disruption, commercial sex work, STDs, and traffic to/from Kinshasa in the period 
1899–1923. Injection treatments increased sharply around 1930; however, their frequency 
among local patients was far lower than among modern groups experiencing parenteral 
HIV-1 outbreaks. Recent molecular datings of HIV-1 M fit better the period of maximal 
resource exploitation and trade links than the period of high injection intensity.  
We conclude that although local parenteral outbreaks might have occurred, these are 
unlikely to have caused massive transmission. World War I led to additional, and hitherto 
unrecognized, risks of HIV-1 emergence. We propose an Enhanced Heterosexual 
Transmission Hypothesis for the origin of HIV-1 M, featuring at the time and place of its 
origin a coincidence of favorable co-factors (ape hunting, social disruption, STDs, and 
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mobility) for both cross-species transmission and heterosexual spread. Our hypothesis does 
not exclude a role for parenteral transmission in the initial viral adaptation. 
Keywords: HIV; SIV; Origin of HIV; zoonosis; Central Africa; genital ulcer disease; 
unsterile injections; bushmeat 
 
1. Introduction 
Simian Immunodeficiency Viruses (SIV) have jumped to humans at least thirteen times, leading to 
four known groups of Human Immunodeficiency Virus (HIV) type 1 (HIV-1) and nine groups of HIV 
type 2 (HIV-2) [1–12]. Both the pandemic strain (HIV-1 group M) and a rare variant only found in 
Cameroon (HIV-1 group N) originated from SIVcpz infecting wild chimpanzees of West Central 
Africa (Pan troglodytes troglodytes) [1–5]. The rare HIV-1 group P, also found in Cameroon seems to 
have originated from SIVgor infecting western lowland gorillas (Gorilla gorilla gorilla) in the same 
region [10,11]. HIV-1 group O, which infects thousands of people mainly in Cameroon and 
neighboring countries, has SIVgor as its closest known relative, but an origin from SIVcpz cannot be 
formally excluded [1,13,14]. All known nine HIV-2 groups are derived from SIVsmm endemic in 
sooty mangabey monkeys from the West African forests. Only HIV-2 groups A and B generated 
substantial human epidemics [4–9]. 
It is widely accepted that the most likely route of simian-to-human transmission of SIV was through 
bushmeat hunting and handling [2–4,9,15–18]. One study reported a prevalence of seroreactivity to 
SIV of 17% in Central African villagers highly exposed to simian bushmeat, significantly higher than 
in unexposed individuals [19]. Other simian retroviruses have found their way into humans through 
similar bushmeat practices, such as simian foamy virus [20] and simian T-cell lymphotropic virus 
(STLV) [21,22]. Only a few of such zoonotic infections have turned into the human epidemics of HIV 
and HTLV. 
Molecular clock analyses were used to estimate the timings of the most recent common ancestor 
(tMRCA) of epidemic human retroviruses. Estimates of tMRCA for the different HTLV-1 subtypes 
span between less than 3,000 and about 50,000 years ago [23,24]. HTLV-2 crossed to humans between 
60,000 and 400,000 years ago [22–24]. In contrast, the tMRCAs of all four main epidemic HIV groups 
(HIV-1 groups M and O and HIV-2 groups A and B) appear to be all very recent and nearly 
simultaneous in the early 20th century [6,25–31]. Similar research showed that the tMRCA of HIV-1 
group M and its closest SIVcpz relative found to date, predates the spread of HIV-1 group M by only a 
few decades, suggesting that the cross-species transmission of SIVcpz giving rise to HIV-1 group M 
must have been in late 19th–early 20th century. This fact suggests that phenomena new in the 20th 
century might have constituted the driving factors of HIV emergence. Among the potential factors, it 
has been noted that bushmeat intensification, forced labour, and smallpox vaccinations performed 
without proper sterilization were common in colonial Afrique Équatoriale Française (AEF; a 
federation of French colonies encompassing French Congo, Gabon, Oubangui-Chari, and Chad), these 
factors potentially increased human exposure to SIV and risks of human-to-human transmission and 
viral adaptation [5]. 




Several authors proposed a major role of unsterile injections in HIV origins. One hypothesis 
proposes that unsterile injections serially transmitting SIV between humans in a chain of 3–4 acutely 
infected people, improved its adaptation to the new host (as happens in experimental serial passage of 
SIV in macaques and monkeys [4]). In this hypothesis such serial transmission chains are rare events, 
but once one happens the resulting adapted virus has long term epidemic potential, even if there is no 
further transmission immediately after the adaptive event [4,32–34]. The critical injections that might 
have fostered the origin of the several HIV groups were hypothesized to be either those of the 
antibiotic era (after ~1950) [4,32] or those belonging to the campaigns against human African 
trypanosomiases (HAT) (which peaked in 1925–1945) [34].  
Another parenteral hypothesis proposes that unsafe injections used in the treatment of tropical and 
infectious diseases (e.g., HAT, yaws, syphilis) might have massively transmitted SIV/HIV in rural 
areas, generating large hubs of infected people, with sexual transmission gaining importance only later 
on [17,18]. It was proposed that HAT treatments performed in southwestern Oubangui-Chari (now the 
Central African Republic (CAR)) exponentially transmitted HIV-1 group M among the Mbimou tribe 
in the 1930s–1940s, causing a large proportion of them to die of AIDS [35].  
Social changes, and/or increased human mobility [3], and the onset of urbanization in colonial 
Africa [27] have also been invoked as explanations for HIV emergence. We proposed that a high 
frequency of genital ulcer diseases (GUD), such as syphilis, chancroid, and lymphogranuloma 
venereum (LGV), a result of those social changes, and possibly also a relatively low frequency of male 
circumcision, in nascent colonial cities may have been the triggers of initial HIV transmission and 
adaptation to humans [16]. GUD induced genital ulcers can dramatically increase HIV transmission 
[16,36,37], and our work suggests that the high prevalence of these diseases might have provided 
crucial “help” for the initial spread of the virus. 
In this article, we will focus on the origin of HIV-1 group M (HIV-1 M). Studies of sera collected in 
the period 1959–1992 (reviewed in [38]), the history of the early African AIDS cases (reviewed in 
[39,40]), the high genetic diversity exhibited by HIV-1 M in the Democratic Republic of Congo (DRC) 
compared to other African countries, particularly in Kinshasa [27,41,42], and a recent phylogeographic 
analysis using HIV-1 M strains from many different DRC locations and from Brazzaville [43] suggest 
that, by 1950, Kinshasa was the main human epicenter of the epidemic [2,15,16,18,27,43]. Thus, this 
city may have been the place where the virus underwent its main initial spread and diversification, 
whether or not early foci first occurred elsewhere.  
HIV-1 M clusters most closely with SIVcpz currently found in southeast Cameroon [2], which 
suggests that the cross-species transmission happened in this part of Africa [2,15]. This motivated us to 
investigate which factors present in these areas in the early 20th century might have been able to 
potentially promote SIV zoonotic transmission, sexual or parenteral transmission of the virus between 
humans, and migration of the virus to major centers. We retrieved colonial reports and archival data 
about Cameroon and AEF, and additional colonial medical, ethnographic and other literature to 
compare the different theories of HIV origins with available information from such archives. 
  




2. Study of Risk Factors 
2.1. The Patchy Prevalence of SIVcpz and SIVgor 
All known HIVs that originated in Central Africa are derived from either SIVcpz or SIVgor. The 
chances for an HIV-1 epidemic to originate in a particular region within the ranges of the relevant 
chimpanzee and gorilla subspecies would depend on local SIVcpz/SIVgor prevalence in wild apes, 
levels of ape bushmeat hunting, and the chance that an infected human carrier would bring the virus to 
a city hub at or near these areas, where transmission factors were favorable to its initial adaptation and 
spread. Most regions watered by the navigable branches of the Congo-Oubangui-Sangha fluvial system 
(which therefore had more contacts with the above cities during the early colonial period) are inhabited 
by either central chimpanzees (P.t.troglodytes), eastern chimpanzees (P.t.schweinfurthii), or western 
lowland gorillas (G.g.gorilla), the reservoirs of SIVcpz and SIVgor. SIVcpz seroprevalence is very 
patchy, with most communities having zero or low seroprevalence, and a minority with a prevalence 
around 30%–60% [2,44,45]. SIVgor seroprevalence is only 1.6% on average and is zero at most 
sites [13]. Ape bushmeat hunting was and is widespread in Central Africa, but its intensity varies 
across regions [16,46–48]. 
2.2. The Region under Study 
HIV-1 M is most closely related to SIVcpz retrieved from the southeast corner of Cameroon, a 
region flanked by the Sangha, Ngoko, and Boumba rivers, from the sites MB and LB (Figure 1) [2]. 
SIVcpz forms phylogenetic clusters associated with regions separated by rivers and other geographical 
barriers, which pose obstacles to chimpanzee migration [2]. This, and the short branches connecting 
HIV-1 M to SIVcpz collected from this area, justify the assumption that this group likely originated in 
the area enclosed by the above mentioned rivers [2,15]. Here we will build on this assumption, while 
recognizing that it would need to be revised, should future evidence indicate that chimpanzee (or its 
virus) migration was more extensive over the century since the origin of HIV-1 M. In this region, 
current SIVcpz prevalence in chimpanzees is 20%–35%, higher than in chimpanzees from Cameroon 
and Gabon as a whole [2,44,49], while hundreds of local gorilla fecal samples did not yield any 
evidence of SIVgor infection [13]. 
  




Figure 1. The region of southeast Cameroon and neighboring Afrique Équatoriale 
Française (AEF) regions circa 1930. Sources: (1) on the SIV surveys: [2,13,15]; (2) on 
other elements: [50–53]. 
 
2.3. Evolution of Ape Hunting Practices over Time 
Most Central African peoples that share their habitat with apes tend to hunt them, although there are 
important exceptions [16,46]. For the studied area, we gathered numerous references documenting the 
hunting of apes throughout the colonial period and beyond, both within the Boumba-Ngoko-Sangha 
enclosure [46,54–59], and in adjacent regions west of the Boumba [46,57,60], south of the Ngoko 
[46,59,61], and east of the Sangha [61–65]. 
According to some sources, the Aka and Baka pygmies that inhabit these regions seldom eat ape 
meat, although they hunt them to supply meat to clients [59,65,66]. However, at least in some of the 
areas, pygmies eat ape meat frequently [63,64]. The non-pygmies of these areas generally eat apes, 
although this is restricted by certain beliefs: often an animal species is thought to represent the clans’ 
ancestors, or to have helped them in the past, this preventing their hunting. For example, gorillas and 
chimpanzees are not killed by a branch of the Bangantu ethnic group, because they are believed to 
have helped their ancestors [67]; some Djem clans regard the gorilla as their totem, and do not hunt 
these animals [60]. It should be kept in mind that clans are often more important than ethnic groups as 
determinants of hunting restrictions [68].  
In many of the ethnic groups of the region, women were traditionally forbidden to or strongly 
discouraged from eating chimpanzee and gorilla meat [46–48,54,56]. Gorilla meat is generally 
preferred to chimpanzee meat [46,48,63,64]. 
In 1907, a French observer noted that the Mbimou people, who live between Yokadouma 
(Cameroon) and Nola (AEF), “loved” to hunt chimpanzees and gorillas. Colonial concessionary 




companies corroborated this [55,56]. Chimpanzee hunting for bushmeat was probably practiced in the 
area around Moloundou in 1910–1912, because a German observer remarked that chimpanzee meat 
was forbidden to women [54]. In the 1930s, the hunter Fred Merfield noted that the Menzime hunted 
gorillas more frequently than the peoples of south-central and southwest Cameroon [47]. 
French and German concessionary companies sold thousands of firearms in the region in exchange 
for rubber and ivory in the period 1895–1910, and observers noted that most local peoples (Bangantu, 
Konabembe, Menzime, Mbimou) owned firearms [46,47,54–56,69]. More than 10,000 had been sold 
by the French Compagnie Ngoko-Sangha (CNS) in the period 1900–1907 [69]. These were mostly 
old-fashioned muzzle-loaded guns (although modern rifles were also sold), with which the hunting of 
apes is difficult and unsafe for a lone hunter. However, it was observed that muzzle-loaded guns were 
used by hunters, jointly with spears and other traditional weapons, to kill gorillas in collective 
round-ups [46,47]. From these descriptions, it is unclear whether muzzle-loaded guns contributed 
greatly to the efficiency of ape hunting; however, villagers with any type of guns may have been more 
willing to hunt, which probably led to more ape hunting. 
Ivory collection was intense in this region in the first decade of the 20th century: already by  
1912–1914 there were worries about the extinction of elephants in the region [56]. Rubber collection 
was forcibly imposed on villagers by colonial companies in exchange for low pay. They had to move 
deeply into the forests, staying separated from their families for weeks, and this increased reliance on 
bushmeat [56,57,70]. The Menzime specialized in supplying bushmeat to rubber collectors and hunted 
apes very frequently [47]. In the early to mid-1920s, the lower post-war demand and increased 
competition from South-American and Asian rubber caused the local rubber prices to collapse [50]. 
This caused the foreclosure of most enterprises of the Mouloundou area in 1922–1923 [47,50]. 
However, a new economic development wave centered on coffee and cacao plantations started at that 
time, and the plantation workers were supplied with bushmeat by specialized hunters [56]. Animal 
skins were procured by concessionary companies and rubber collection continued, albeit reduced. In 
addition, men working in road construction (more important since the late 1920s) may have been 
supplied with bushmeat too, since this was common in Central African enterprises [71,72]. These 
activities probably maintained a high level of human exposures to SIVcpz and SIVgor even after the 
end of the “rubber and ivory” period.  
From 1916 onwards, the AEF administration introduced measures to protect wildlife, including 
elephants and gorillas (but not chimpanzees) [56]. New hunting laws and permits were enacted in 
1929–1930, in both AEF [56,73] and Cameroon (report of the French administration of Cameroon to 
the League of Nations, 1930 [50]). Chimpanzee hunting became restricted to holders of scientific 
permits. Gorilla hunting became restricted to holders of either scientific or “sportif” (touristic) permits 
(who were almost always European), and holders of special large game permits (which could be 
privileged Africans).  
The enforcement of these laws was difficult in interior areas, where colonial administrative 
personnel visited less frequently. Accordingly, we read numerous descriptions of ape hunting in which 
the law was violated: Merfield observed collective round-ups of gorillas practiced by the Yaunde and 
the Menzime in Cameroon, in the late 1920s and 1930s [47]; Denis observed such practice among the 
Mbeti (French Congo) in the 1940s [46]. In the Belgian Congo, where similar laws protecting apes 




existed [74,75], live infant chimpanzees were being traded in the 1950s [39,40]; this implies that their 
parents had been killed [39,76], at a time when colonial administrative control was at its peak. 
With decolonization, in 1960, hunting law enforcement degraded even further, modern firearms 
became more available, and bushmeat became increasingly commercialized, accelerating the collapse 
of the chimpanzee and gorilla populations (worldwide, chimpanzees were between one and two 
million in 1960, and had declined to 170,000–300,000 in 2003 [77–79]). We can tentatively suggest 
that ape hunting was less intense in the period 1930–1960, when the relevant protective laws were 
being partly enforced, than either before or after that. 
2.4. Nosocomial Risks  
2.4.1. General Trends 
Parenteral risks such as posed by unsterile injections and vaccinations could have favored initial 
HIV spread in both rural areas and cities. In this article we attempt to quantify these risks in the rural 
area under study, while recognizing that quantifying them in the colonial cities more probably 
associated with early HIV spread (e.g., Kinshasa) is a worthwhile project.  
Several reviews indicate that the broadest (in the sense of number of people covered) healthcare 
interventions involving injections/inoculations in rural Central Africa up to Word War II were 
smallpox vaccinations and treatments against HAT and treponemal diseases (yaws and syphilis) 
[17,18,34,72]. Figure 2 displays the annual numbers of these interventions in Cameroon. 
Figure 2. Reported annual numbers of treatments against human African trypanosomiasis 
(HAT) (only newly diagnosed cases), syphilis and yaws, and of smallpox vaccinations in 








2.4.2. Smallpox Vaccinations  
Colonial medical authors had expressed concern about the parenteral risks of smallpox inoculations 
from very early times. One, writing in 1906, reported that catheters were carefully boiled between 
inoculations of Tirailleurs (the elite African troops) [80]. In vaccinations of the general African 
population the standards of safety were probably lower, although several sources of the early 1920s do 
mention sterilization procedures [81,82], such as plunging catheters in a saucer with burning 
alcohol [82]. Such “flaming” procedures do effectively kill retroviruses like SIV or HIV; however we 
do not know how often vaccinations were performed with inadequate or no sterilization procedures. 
Jennerian inoculations were practiced in Cameroon and AEF throughout the colonial period. They 
were often ineffective, and this prompted medical authorities to revaccinate people often. In the period 
1922–1940, the annual inoculation rate in the population of French-administrated Cameroon was in the 
range 12–22% [50], so each person was being inoculated once every 5–8 years. In AEF, the frequency 
was slightly lower [51,72]. This frequency of parenteral exposures was much lower than in injection 
treatments (the latter will be reviewed below). 
In the period 1890–1910 there were shortages of viable vaccine in interior regions because the heat 
during the long journey to the interior often caused them to lose effectiveness. Pressed by smallpox 
epidemics, doctors performed arm-arm inoculations: they collected lymph from the pustule of a 
recently vaccinated person to vaccinate the next. As was well recognized at the time [81], this 
procedure causes a much higher parenteral risk because more lymph is transferred than in normal 
unsterile catheter reuses. Some of these interventions were done by the French in “Haute Sangha”, 
which normally designates the region to the north of (and including) Nola [80,83,84]. Lymph was 
collected from relatively few individuals, each donating to many people, and lymph was gathered from 
their pustules 4–5 days after inoculation [84–86]. This practice was, however, less common than the 
normal method of Jennerian inoculation.  
2.4.3. Yaws and Syphilis Treatments 
In Cameroon, anti-treponemal treatments rose sharply in 1925. They multiplied 10-fold between the 
early 1920s and the 1950s [50,87–97] (Figure 2), i.e., with a peak later than the origin of the more 
widespread HIV-1 groups (M and O). In forested areas (as in the region where HIV-1 M came from) 
yaws was more common than syphilis. In the 1920s and 1930s, 90%–95% of people treated for yaws 
were children [94,98]—less likely to be SIV- or HIV-infected. 
The most important drug used against these diseases was the arsenical compound neoarsenobenzol 
(called neosalvarsan or neo), available since 1912, soon after its predecessor arsenobenzol. It was 
administered intravenously. Other arsenical compounds, and bismuth and mercury compounds were 
also used. Bismuth was administered intramuscularly or subcutaneously [99–101] and, being better 
tolerated by Africans than mercury, became increasingly preferred [102]. Orally administered 
stovarsol was also heavily used. To attempt complete cures of syphilis, prolonged treatment regimens 
involving many injections (combining an arsenical with other compounds) were recommended [103]. 
Accordingly, the best anti-venereal disease hospitals, clinics, and dispensaries in urban centers often 
administered many injections per patient. For example, in the Institut Policlinique de Dakar, in 1933 




and 1934, syphilis patients received an average of 17 and 25 injections per year, respectively; in the 
Vernes Dispensaries of Madagascar, in 1934, the average was 17 [94]; in the Croix Rouge du Congo of 
Leopoldville-East, the averages of injections per syphilis patient per year, in the period 1933–1940, 
were in the range 15–24 [101].  
However, in less favored dispensaries and in rural areas, much fewer injections were given [92,94]. 
For example, in non-specialized Madagascar dispensaries, in 1934, the average was 3.7 injections per 
syphilis patient per year, of which 1.25 were of arsenicals [94]. We refer these Madagascar data 
because only for this colony the French articles we reviewed provide the figures of injections per 
patient for "normal" (non-specialized in venereal disease) dispensaries. This is relevant, because the 
dispensaries existing in the region under study were also non-specialized. Several authors writing 
about syphilis and yaws treatments in medical tournées by rural areas of AEF and Cameroon in the 
1920s and 1930s, state that the average patient received just one or two neosalvarsan injections 
[98,92,104]. This is corroborated by the administrative reports of Cameroon sent to the League of 
Nations: in the period 1922–1931 the average number of such injections per treponematosis patient per 
year was in the range 1.0–1.9 (or 1.4–2.3 counting mercurial and sulfarsenol injections) (Table 1) 
[50,88,105]. 
Table 1. Injection treatments against treponematoses in Cameroon, 1922–1931. Sources: [50,88,105]. 
Year 
# of treponematoses cases # of injections # of injections/patient/year 
Syphilis Yaws Neosalvarsan Mercury salts Sulfarsenol Neosalvarsan Others 
1922 8,285 6,129 27,800 NA NA 1.93 NA 
1923 8,237 6,552 20,050 NA NA 1.36 NA 
1927 32,303 18,930 59,200 15,274 22,310 1.16 0.73 
1928 42,015 24,718 76,270 18,158 59,450 1.14 1.16 
1929 40,341 30,031 75,567 20,128 4,731 1.07 0.35 
1930 35,693 29,701 77,728 23,085 15,591 1.19 0.59 
1931 42,730 29,086 106,669 27,800 32,680 1.49 0.84 
NA: Not available. 
2.4.4. The HAT Campaigns 
Two drugs constituted the main arsenal against HAT (sleeping sickness) in Central Africa, until the 
Second World War: atoxyl, administered intramuscularly, which had little therapeutic value, and 
tryparsamide, administered intravenously, which permitted cures in advanced disease. Other 
intravenous drugs were used in the 1930s, but their combined number of injections was considerably 
lower than that of tryparsamide. In AEF, Belgian Congo, and German Kamerun (we will use this 
spelling to refer to Cameroon under German colonization, 1884–1916), atoxyl started to be used 
around 1907–1909 [72,106,107]. Colonial doctors believed that atoxyl could clear the peripheral blood 
from trypanosomes and thus, injecting rural people on a large scale would prevent the spread of the 
epidemic. They performed numerous “tournées d'atoxylization” in many rural areas of Central Africa 
in the two decades following 1907, administering usually one or two injections to each person infected 
or suspected to be infected [72,108–112]. Several injection campaigns were performed by the French 
in Haute Sangha (including Nola) in the period 1907–1913 [83,109,112]. Others were performed by 




the Germans in the Nola region (which was annexed to Kamerun in the period 1911–1914 following a 
Franco-German agreement) and in neighboring southeast Kamerun, where the disease was observed on 
the banks of the Ngoko [72,113]. These tournées were very irregular: some interior regions were not 
visited at all for many years; and, particularly in the 1920s, some regions were visited often, causing 
some people to receive six and sometimes more injections per year [72,114]. 
Tryparsamide started to be used in the mid-1920s, and was administered in series of weekly 
intravenous injections (with varying regimens). HAT campaigns peaked earlier than syphilis and yaws 
treatments, i.e., nearer to the calculated tMRCAs of HIV-1 groups M and O [26–30]. In Cameroon, 
they had a sharp peak in 1926–1928 (Figure 2), when Eugene Jamot started more organized campaigns 
based on mobile teams that visited most of the population [50,115–118]. A few years later, similar 
teams were put in place in AEF [72,119]. Review articles about these organized campaigns of  
French Cameroon and AEF show that each patient received 15–24 injections, spread over a period  
of treatment of two or more years. More than half of the injections were of the cheaper and  
non-intravenous atoxyl [115,116,120].  
This suggests that the organized HAT campaigns, during their peak period in Cameroon and AEF 
(broadly 1926–1940), involved considerably higher parenteral risks than syphilis and yaws treatments 
in the same regions. Probably, the early “atoxylization” campaigns (1907–1926) posed lower 
parenteral risks than the more organized ones (which started in 1926): they were irregularly done, each 
patient received relatively few injections, and these were intramuscular or subcutaneous. 
Colonial health reports mention the number of HAT patients surveyed (newly found ill or old 
patients revisited). All new patients, and some of the old ones were treated. In 1930, the surveyed HAT 
patients in AEF received on average only 3.05 injections each (the average of those effectively treated 
was higher; we cannot calculate it because the proportion of surveyed old cases treated was seldom 
quantified in the reports). This average increased throughout the 1930s (Table 2).  
Table 2. Injections against human African trypanosomiasis (HAT) in Afrique Équatoriale 
Française (AEF). All “new” cases were usually treated with around 12 injections; however, 
in 1930, this was probably less, given the total number of injections reported. Not all 
surveyed “old” cases were treated. Sources: [90,94,95,97].  
Year 
# of surveyed HAT cases 
# of injections 
performed 
# of injections per patient per year 
New cases Old cases All surveyed cases 
New cases  
(all treated) 
Old cases 
1930 12,649 34,611 144,168 3.05 6–8? 1–2? 
1934 13,368 42,508 254,000 4.55 ~12 2.20 
1935 12,557 54,709 262,424 3.90 ~12 2.75 
1937 16,597 60,196 597,409 7.78 ~12 6.62 
2.4.5. The Early 1930s: Intensification of Injection Treatments 
The organized HAT campaigns in Cameroon started in 1926, and the number of newly identified 
patients peaked in the period 1926–1928 (Figure 2). However, this effort did not arrive to the southeast 
district of Yokadouma (which encompassed the Cameroonian banks of the Ngoko and Sangha river; 
Figure 1) until 1932, when this area was first visited by the mobile teams [50,92]. The teams, which 




visited almost all inhabitants, found 14% of them infected (44% in the southern areas near the 
Ngoko) [50]. Each infected person may have been treated with more than 15 injections in the next few 
years (see above). In addition, the report of Cameroon for that year [50] states that the district never 
had continuous medical action before. Thus, the year 1932 brought unprecedented levels of parenteral 
risks to southeast Cameroon. 
Anti-HAT campaigns in the neighboring AEF regions of Nola and Ouesso peaked after 1929–1930, 
although there was some activity before [72]. In Nola, there were only 380 new HAT cases treated in 
1930, and the number rose sharply after that (Table 3). The Mbimou people, who live between 
Yokadouma and Nola were the main focus but were only systematically treated in the 1930s (Table 3 
and related references). However, according to a reviewer, they were being insufficiently treated at 
least until 1935 [121]. Our own research of the relevant AEF reports [51] reveals that each surveyed 
(new or old revisited) HAT patient from Nola (mostly Mbimou) received an average of 4.58 injections 
in 1933 and 4.59 the following year. 
Table 3. Systematic treatments against human African trypanosomiasis (HAT) in southeast 
Cameroon and neighboring districts of Afrique Équatoriale Française (AEF), up to 1936. 
Dashes indicate no systematic activity, according to the reports. Some of the old cases were 
also treated. Sources: [50,51,87–97]. 
Year 










1927 – – – – – – 
1928 – – 228 222 108 ? 
1929 – – 77 176 212 242 
1930 – – 380 ? 154 356 
1931 – – 594 2,371 116 457 
1932 2,928 – 590 1,812 130 957 
1933 ? ? 885 3,409 177 1,632 
1934 43 2,928 1,463 2,516 184 818 
1935 ? ? 1,816 7,342 b b 
1936 74 1,036 3,464 3,721 b b 
a Yokadouma was included in the Boumba-Ngoko sector. b Ouesso was included in the 
Ngoko-Sangha sector up to 1934, and in the Sangha sector (jointly with Nola) after that. 
 
Therefore, the early 1930s brought unprecedented levels of parenteral activity to southeast 
Cameroon and neighboring AEF areas: not only were anti-HAT campaigns systematically performed 
by then, but the same mobile teams also boosted anti-syphilis and anti-yaws treatment. 
Most calculations of HIV-1 M’s tMRCA published recently produced results in which the upper 
interval of the highest probability distribution falls before 1930 (with a few exceptions) [27,30]. This is 
illustrated in Figure 3, and suggests that HIV-1 M probably originated at a time when parenteral risks 
in the studied region were considerably smaller than in the 1930s. 
  




Figure 3. The recent tMRCA calculations of HIV-1 M (with high probability (HPD) 
distribution intervals), and the timings of systematic treatments against human African 
trypanosomiasis (HAT) in the districts of Yokadouma (Cameroon) and Nola (Afrique 
Équatoriale Française). Sources: (1) on tMRCA calculations: [27,30]; (2) on HAT 
treatments: [50,51,87–97]. 
 
2.4.6. Health Facilities 
During the German period, there was an important medical facility in Moloundou [122]. In the 
1920s and early 1930s, Moloundou and Yokadouma had only dispensaries run by nurses [72]. In the 
neighboring AEF areas, only Ouesso and Nola had a doctor each until 1934, whereafter a third medical 
post, in Berberati, is mentioned in the reports [51]. In the 1920s and early 1930s, there were a few 
nurse-operated dispensaries in Souanké and Sembé (west of Ouesso) and in Berberati and Carnot 
(north of Nola). In 1931, a new one was set up in Gamboula, at the AEF-Cameroon border [51]. 
During these decades, segregation camps for HAT patients (hypnoseries) existed in Ouesso and Nola 
(the latter since 1909). Leprosariums were set up in Nola and Berberati in the early 1930s. In addition 
to these facilities, missions provided some healthcare [50,51,72,121]. In these facilities, the number of 
injections per patient in HAT, syphilis, and yaws treatments was probably higher than in rural villages. 
2.4.7. Comparison with Modern HIV Parenteral Outbreaks 
In an HIV-1 outbreak in Romanian orphanages, children received around 147 injections per year 
(according to a detailed study based on one of the orphanages) [123]. Estimates for injection intensity 
in nosocomial outbreaks in Elista, Russia, and in Lybia give an annualized rate of 40–200 and 52, 
respectively; in both of the latter outbreaks, HIV-1 transmission was probably boosted by the use of 
venous catheters and lines in many patients; no reliable estimates exist for the other outbreaks [124].  
Studies of intravenous drug users (IDU) estimated that they inject themselves around ~700  
(300–1,800) times a year [125–131]. In Western IDUs, explosive HIV-1 spread happened more 
commonly in the 1980s (with prevalence attaining 15%–70%), when they shared needles more 
frequently and needle exchange programs, methadone, and other harm reduction interventions were 
still incipient or non-existent [125,132–136]. For IDUs observed at the start, or in early stages, of these 
interventions the average frequency of needle sharing (counting all individuals including non-sharers) 




was normally in the range 60–245 needle sharing events per year (and much higher counting sharers 
only) [125,131–133,137]. 
While in some IDU communities the sharing frequency remained similarly high despite 
interventions [126,127], in others the interventions were very successful in reducing the needle sharing 
frequency to 10–30 per year (and sometimes to <10) [129,130,135,138]. In the latter cases HIV-1 
prevalence either is very low, or is persistently stable or declining. For example: (1) in Australia, 
interventions were very effective, annual needle sharing rate is <10, and HIV-1 prevalence is stable at 
~1% [129]; (2) in Edinburgh’s IDUs, after explosive HIV-1 spread in the early 1980s, effective 
interventions reduced needle sharing rate to <20 per year, and HIV-1 prevalence remained stable 
around 20% during many years [138]; (3) a similar pattern was observed in several Dutch cities 
(estimated annual needle sharing rates of ~23 in Rotterdam and ~14 in Arnhem) [135], and in Montréal 
(estimated annual needle sharing rate of ~27 [130]; (4) in Vancouver, HIV-1 prevalence was stable at 
3–4% in the period 1984–1994, and annual needle sharing rate was estimated at ~30 [139]; (5) the 
IDUs from Bristol, UK, were estimated to share needles 48 times per year and had only 1% HIV-1 
prevalence, while those from Teesside, UK, shared needles 14 times per year and had zero HIV-1 
prevalence [140]. Such data seem to suggest that the above sharing frequencies do not enable HIV-1 
rapid spread in IDUs. 
Our research indicates that syphilis and yaws patients in Cameroon, in the period 1922–1931, were 
receiving only 1.4–2.3 injections per year (Table 1); in rural dispensaries, the average per syphilis 
patient could be twice that number [94]. In AEF, in the period 1930–1935, surveyed HAT patients 
received 3–5 injections per year, and by 1937 this had increased to 7.8 (Table 2), although newly 
found patients would receive around 12 injections in the first year (Section 2.4.4). In rural hypnoseries 
the average patient could receive more injections but, in the 1930s, the standard treatment was 
12 injections. Reviews indicate that patients received 15–24, spread over two or more years 
(Section 2.4.4). Even in the unlikely scenario of these injections being all unsterile, their frequency 
was much smaller than either the injection frequency in modern nosocomial outbreaks, or the needle 
sharing frequency among IDUs (including non-sharers) suffering explosive HIV-1 spread (60–245 per 
year), and was comparable to the sharing frequency among IDUs with low and/or stagnant HIV-1 
prevalence. A comparison of the injection intensities in Central African health campaigns, among IDU 
communities, and in modern HIV outbreaks can be seen in Figure 4. 
2.5. Sexual Promiscuity and Sexually Transmitted Diseases  
In the early 20th century, Central Africa suffered rampant epidemics of STDs, including genital 
ulcer diseases (GUD), such as syphilis and chancroid, particularly in the nascent colonial cities and 
socially disrupted semi-rural colonial posts. Syphilis was absent from most forested areas  
where chimpanzees and gorillas live, up to about 1885, when colonial control of the interior began  
[72,141–145], although it was present at the coast [72,146,147] and in savannah-forest interface 
regions connected to the Muslim states of the north [141]. The probable reason for this absence was 
the absence of commercial sex workers (CSW) with levels of sexual promiscuity comparable to those 
operating in the West [16,147–149]. 




Figure 4. Comparison of injection intensities in the Central African campaigns (first three 
categories) and relevant modern populations (remaining categories). (ani): annual number 
of injections; (anns): annual number of needle shares. The seven categories, from left to 
right, are as follows: (i) to (iii) Central African data, based on our review (Tables 1 and 2); 
(iv) available estimates for nosocomial outbreaks (sources: [123,124]); (v) estimates of 
needle sharing for IDU groups in which HIV-1 prevalence was either <5% or stagnant 
since many years previous to observation (sources: [129,130,135,138–140]); (vi) estimates 
of needle sharing for IDU groups in which HIV-1 prevalence was >10%, had risen fast in 
previous years, and the study could observe needle sharing rate at the onset of a needle 
exchanging program, methadone, or other intervention (known to cause dramatic drops in 
needle sharing) (sources: [125,128,131–133,136,137]); (vii) estimates of annual number of 
injections (with or without sharing) for IDUs (sources: [125–131,140]). For each category, 
the range and average between studies are shown. 
 
 
In the early colonial period, administrative and trading posts were founded, with frequent steamer or 
railway connections to cities. Although their permanent population was no larger than that of a village, 
they had a high turnover of predominantly male passers-by, consisting of soldiers, traders, porters, and 
laborers. As happened in cities, generalized social disruption ensued in the colonial posts and 
enterprises located in the interior, and sex work and syphilis flourished [72,105,141–143,150]. 
Several sources mention the presence of STDs in the region since early colonial times. The 
Fourneau-Fondère expedition arrived to Ouesso (a French post since 1891 [151]) in 1899 with five 
Europeans, 36 African soldiers, and around 200 porters. Several men contracted blennorrhea and at 
least one contracted a chancre (of either primary syphilis or chancroid) in Ouesso, after a stay no 
longer than one month [152]. According to a contemporaneous reviewer, CSWs generally operated 
close to colonial military posts [143]. In the period 1891–1902, syphilis was already common in the 
Sangha posts (Ouesso, Nola, Bania), mainly driven by the movement of troops, and was still absent 
from interior villages [143,152]. Haoussa traders also spread STDs in the region early [153]. 




In the first decade of the 20th century, the French Compagnie Ngoko-Sangha and the German 
Gesellschaft Süd-Kamerun (GSK) intensified exploitation of local resources in the region, leading to 
unprecedented movements of people and social disruption. Moloundou was the administrative center 
of the German southeast Kamerun district, and the main GSK headquarters. The path between 
Yokadouma and Moloundou became frequented by thousands of soldiers and porters transporting 
rubber, ivory, and other products. In 1911, the number of soldiers, porters, rowers, and other African 
workers in the district was 1,500 (mostly young males), hired elsewhere in Cameroon, in Congo, or in 
other Central African colonies; the non-pygmy native population of the district was around 12,960, of 
whom 3,716 were adult males and 4,563 were adult females (including old adults) [54]. The sex ratio 
of young adults was then significantly male-biased for a rural area. Many men frequented the socially 
disrupted colonial posts and did not follow a rural lifestyle. Inevitably, commercial sex work became 
commonplace [54]. The peak intensity of a biased sex ratio and the disruption of the traditional social 
network probably occurred in the period 1908–1916. 
We found limited direct data on the incidence of STDs and sexual promiscuity in the region of 
study. The high levels of social disruption and biased sex ratio suggest that STDs may have been as 
incident as in contemporaneous colonial troops stationed in other regions. A review of STD and GUD 
incidence in French colonial troops from all colonies in the period 1903–1906 indicates overall 
syphilis and chancroid annual incidences in the ranges 3.2%–4.1% and 5.1%–6.9%, respectively. In 
the more CSW-ridden Caribbean colonies these incidences were 7.3% and 13.3%, respectively [154]. 
Almost all syphilis detected in troops was either primary or secondary; primary syphilis is 
characterized by a genital chancre and secondary syphilis causes genital ulcers in a substantial fraction 
of patients [155]. 
The health reports of French Congo show the numbers of consultants (treated cases) for syphilis 
and the population partitioned between adults and children of the Ouesso (or Ngoko-Sangha) district in 
the period 1932–34. The reported syphilis incidence in adults in these three years was 4.8%, 5.2%,  
and 19.9%, respectively. The same reports show the number of consultations for syphilis  
in the Nola subdivision (which was part of the Haute Sangha district) [51]. Assuming the Nola 
consultations/consultants ratio is the same as in Ouesso, we can estimate the numbers of consultants in 
Nola; based on that we estimated syphilis incidence in Nola at 10.7% in 1933 and 15.2% in 1934. Part 
of these cases could be tertiary or serological manifestations of yaws, which were hard to distinguish 
from syphilis [51]. The very high reported incidence in 1934 may reflect an increase in treatments and 
serological diagnoses [51]. 
2.6. Travelling and Migration of People to/from the Stanley Pool Cities 
We attempted to obtain information about migration of people from the studied area to cities, or to 
work in the French railway construction (1921–1932) and the Belgian railway upgrade works  
(1923–1931). We collected census/survey tables of colonial cities that partition inhabitants by 
ethnic/regional origin. These tables appear sporadically in archives, articles, and books. Some were 
published as supplements to our previous article [16]. For the period 1927–1934, the number of 
immigrants from either southeast Cameroon or the Nola area recorded in Leopoldville and Brazzaville 
censuses is negligible. However, these censuses likely missed floating populations and illegal 




immigrants, and also may have misrepresented the real origin of immigrants, so we cannot conclude 
that the real number was negligible. Also, we did not obtain similar censuses from before 1927. 
Additional research is needed to quantify these migrations in more detail. 
During the colonial period the region was economically more dependent on the large southern cities 
of the Stanley Pool (Leopoldville-West, Leopoldville-East (Kinshasa), and Brazzaville) than on 
western Cameroon, because of the easy transportation highway provided by the Congo-Sangha river 
system. Local firms used the Belgian railway between Kinshasa and the Atlantic port of Matadi, 
available since 1898, to export their products. The French companies used the Belgian railway until 
1932, when a second railway connecting Brazzaville to Pointe Noire was completed, diverting most of 
the region's exports from the Belgian railway [72,151,156,157]. In the period 1899–1914 the German 
connections to Kinshasa were particularly intense. The GSK was exploiting the resources of southeast 
Kamerun more intensively than its French counterparts in neighboring AEF, and it had large 
warehouses in Moloundou [54,122,151,156]. Both the GSK and the associated Kameruner Schiffahrts-
Gesellschaft had steamers navigating between southeast Kamerun and Kinshasa, and Belgian archival 
documents refer to warehouses and other property owned in Kinshasa by these two German 
companies [158]. For example, on the day the First World War broke out, four German steamers were 
docked in Kinshasa, which illustrates the intensity of the commercial links between the city and 
southeast Kamerun [122]. The German administration and enterprises in Moloundou employed men 
described as “Bangala” [54]. This designation could mean they belonged to the Bangala tribe from the 
Belgian Congo (of which our previous research revealed that many men were in Kinshasa [16]), or 
speakers of Lingala, a trade language by then dominant in the Congo basin's colonial posts [159]; in 
either case they could well have frequented or inhabited the Pool cities. 
After the mid-1920s the rubber business of the region declined, and coffee and cacao plantations 
overtook rubber in economic importance in the region (Section 2.3.3). Several important plantations 
were set up around Nola, Berberati, and at the Sangha banks, more than in southeast Cameroon [56]. In 
the 1930s, these regions probably generated more traffic to and from the southern cities than southeast 
Cameroon, and after 1932, when the French railway became available, this traffic was probably being 
increasingly directed to Brazzaville rather than to Kinshasa. In addition, the increasing importance of 
roads after the 1930s intensified the region's links to western Cameroon, and reduced its reliance on 
the Stanley Pool. Trade connections between southeast Cameroon and the Pool peaked in the period 
1899–1923. 
During the First World War, intense military operations occurred in the region. French forces took 
Nola in October 1914. Franco-Belgian forces conquered Moloundou in December and Yokadouma in 
January 1915. These forces totaled about 2,000 soldiers and had thousands of porters helping them. 
They stayed in southeast Cameroon for five months, before resuming the offensive to the west. They 
“encouraged” (forced?) local people to supply them with food. During these five months and beyond, 
through February 1916, numerous steamers supplied troops from Brazzaville and Leopoldville [122]. 
The numbers of soldiers and porters involved were stressful for a district with about 14,000 native 
people [54], and the sex ratio around the posts where the soldiers were camped became inevitably 
extremely male-biased. Although the war in Cameroon lasted only 18 months, it involved intense 
steamer movements to/from the Pool cities, intense soldier and porter movements in the 
interior [122,160], grave food shortages among combatants and reliance on bushmeat [160,161]. 




Deserters formed armed bands that roamed the region for pillage, even after the war [151]. It should be 
noted that both the regular troops and the bands of deserters had modern cartridge weapons, with 
which hunting of apes is far more effective [46] than with the muzzle-loaded guns available to most 
rural hunters. The war operations may have increased human exposure to SIVcpz and SIVgor, sexual 
promiscuity, and the probability of a zoonotic virus to arrive at the Pool cities. 
During the war, German troops retreated from areas of Gabon and Congo-Brazzaville into 
Cameroon, and concentrated in Yaoundé and Ebolowa, the two larger urban centers that they 
controlled during most of the war. Invading French troops moved from the same countries into 
Cameroon and were stationed in the same cities when the war ended. German troops retreated to 
Equatorial Guinea (a neutral Spanish colony at the time), dragging tens of thousands of civilians with 
them. Most of these military and civilians moved back into Cameroon (passing by Douala and other 
cities) soon after [122,160]. More than 50,000 people were involved in these movements 
[122,145,160]. Thus, the war caused an unprecedented transit of people between Cameroon and 
neighboring regions of Congo-Brazzaville, CAR, Gabon, and Equatorial Guinea, and particularly of 
highly mobile people, relying on bushmeat while in the forest, and moving from forest areas to 
Cameroonian cities (Douala, Yaoundé, Ebolowa). At least in Douala, CSWs and GUD were abundant 
[50,99,105,162]. Thus, the unprecedented movements of people associated with the war may have 
been associated with the origins of the HIV-1 groups M and O, since both are dated from around the 
same time [27–30]. 
3. Discussion 
As many authors suggested, HIV-1 M probably started to spread substantially in Kinshasa, whether 
or not initial foci started in Brazzaville or other towns or colonial posts [2,15,16,18,27]. Even though 
old samples from other cities have not been available up to date, not only viral genetic diversity 
including in old samples [27,41,42], but also phylogeographic calculations [43], and epidemiological 
data [38,39] favor Kinshasa as the initial epicenter of pandemic HIV-1. 
SIVcpz is endemic in southeast Cameroon and the neighboring Nola area (Figure 1), where 
currently the SIVcpz closest related to HIV-1 M has been found (reported at sites MB, LB, and BY 
(Figure 1)), with a prevalence over 30% in the MB community, which is higher than the average of 
either central or eastern chimpanzees [2,44,45]. We show here that ape bushmeat hunting was already 
widespread in the region in the period 1900–1910, probably boosted by massive gun selling in the 
area. Local clans had a higher cultural inclination to hunt apes than elsewhere in Cameroon. Ape 
bushmeat hunting was probably more intense in the period 1899–1930, when the rubber business 
peaked, and laws protecting chimpanzees had not been enacted yet. Ape hunting was more common in 
southeast Cameroon and around Nola than in southwest and south-central Cameroon (Section 2.3). 
Considering the “patchiness” of both SIVcpz/SIVgor prevalence and ape bushmeat intensity 
(Section 2.1), southeast Cameroon and the neighboring Nola area might have been particularly 
permissive for cross-species transmission of HIV-1-like viruses.  
We also show that during the period 1899–1923, the most likely timing of the origin and initial 
spread of HIV-1 M, southeast Cameroon and the neighboring Nola area (Figure 1) had intense steamer 
traffic to/from Kinshasa (Section 2.6), surpassing neighboring AEF regions, and probably matching 




many regions of the Belgian Congo in this regard. Both Kinshasa and Brazzaville are located in the 
Stanley Pool constituting the main attraction and hub for traders, laborers, migrants, and soldiers of the 
giant fluvial system encompassing the navigable branches of the Congo, Oubangui, Sangha, and 
relevant tributaries during the colonial period. The trade relations of southeast Kamerun with Kinshasa 
were intense in the German period (1899–1914). At the same time, the social disruption of the region 
was high, with a substantially male-biased sex ratio in young adults, thousands of soldiers, porters, and 
workers moving between posts and to/from Kinshasa, and CSWs and STDs were present [54,70].  
The First World War added specific risk factors that may have helped HIV-1 M to emerge. 
Although the war lasted only 18 months in Cameroon, thousands of soldiers, armed with modern 
weapons, and thousands of porters moved in the region of study, relying on bushmeat and confiscating 
food from local inhabitants, thus forcing them to increase their reliance on bushmeat as well. Armed 
bands roamed the region. Sexual promiscuity and rape are likely to have happened. Steamer traffic 
to/from the Stanley Pool cities also intensified [122,151]. While we want to focus here on HIV-1 M, 
the war hypothesis deserves further attention also for the origin and spread of HIV-1 O, which has a 
tMRCA roughly coinciding with that of HIV-1 M [27–30].  
In currently observed human SIV infections, including among laboratory workers, the viral load is 
undetectable [19,163], suggesting lack of adaptation and transmissibility past acute infection. 
However, if “nascent HIV”, after the initial cross-species transmission was only transmissible among 
humans during acute infection, then the origin of HIV-1 M required an initial series of acute 
transmissions. Either the first human case (e.g., a bushmeat handler) must have carried the virus to a 
city during the short time frame of his/her acute infection, or there might have been some local human 
spread of the virus close to its geographic origin, followed by a migration to a city hub.  
In our previous work we showed that, in the early 20th century, Kinshasa had a strongly 
male-biased sex ratio, the presence of CSWs, most women unmarried, a high GUD prevalence, and a 
lower level of male circumcision than it has today. In Kinshasa the sex ratio was more biased, sex work 
was more flourishing, and male circumcision was less common than in neighbouring Brazzaville [16]. 
We modeled the initial spread in humans of a nascent SIVcpz/HIV-1 M ancestor virus (transmissible 
only during acute infection) in Kinshasa [16]. Our simulations show that initial heterosexual spread of 
such a virus would have been much more probable under the conditions prevailing in the city in the 
early 20th century—particularly a high GUD prevalence [16,101]—than either in the preceding or in 
the subsequent periods. In our sensitivity analyses, we let the simulation parameters vary under 
realistic values, and we tested 51 different scenarios. GUD prevalence appeared to be a key determinant 
of the magnitude of the simulated epidemics and was crucial to allow for long chains of transmission 
[16]. In our simulations, the effects of GUD and acute infection in transmissibility combined in a 
multiplicative way, a method that has been used in other major published models [164,165]. Using an 
additive model, the effect of GUD for HIV-1 initial spread becomes less dominant [166]. However, 
our simulations included, for simplicity, random periods of GUD ulcerations in the affected 
populations (GUD transmission itself was not explicitly implemented), and thus, the real magnitude of 
the GUD effect may have been underestimated. We intend to upgrade our models, both the 
multiplicative and the additive, by implementing explicit transmission of GUD, which might generate 
strong correlations between GUD and HIV prevalence in the most connected parts of the sexual 
network and thereby intensify the effect of GUD prevalence on HIV transmission. We did not include 




the contribution of unsterile injections to the origin and initial spread of HIV-1 in Kinshasa in our 
model, but we recognize that such contribution is plausible since injection intensity was high in some 
of the city's health facilities in the 1920s and 1930s [18,101,167]. 
It has been proposed that unsterile injections given in rural Central Africa exponentially amplified 
HIV-1 to thousands of infections from a single SIVcpz-infected human [17,18,35], which would assign 
a major contribution of rural injection campaigns to the origin of HIV-1 M. In this paper, we attempted 
to assess the injection intensity of such campaigns around the time of the HIV-1 M origin, to have a 
semi-quantitative appreciation of their possible role in early HIV spread, and to have sound 
information on which to base future modeling efforts. We found that at present unsterile injections are 
not capable of sustaining an HIV-1 epidemic without extremely high rates of needle sharing, even 
though modern HIV-1 is probably more efficient at human-to-human transmission than the initial 
virus. In the general populations of modern Africa, unsterile injections are still relatively common, and 
they only account for an estimated 2.5% of all HIV infections [168]. HIV-1 has spread parenterally 
only in selected populations, such as IDUs practicing needle sharing and in hospital outbreaks. IDU 
epidemics are characterized by exposures of >60 unsterile injections per year (Section 2.4.7). 
Remarkably, even IDU populations highly infected with the Hepatitis C Virus (HCV), seem to  
have patchy HIV prevalence, with highly variable prevalence rates among neighboring groups 
[126,127,129,130,140]. 
Comparable levels of exposure cannot be documented in early 20th century rural Africa 
(Section 2.4.7). With an average injection intensity of around 12 injections per year for newly 
diagnosed HAT patients and less for old revisited HAT, syphilis, and yaws patients (Sections 2.4.3 to 
2.4.5), the Central African campaigns might have massively spread HCV [17,169] (as happened with 
anti-schistosomiasis campaigns in Egypt, which had similar injection intensity [170]), but are unlikely 
to have spread HIV-1 extensively [129,130,135,138–140].  
During the HAT and other campaigns done in rural Central Africa in the 1920s–1940s, people 
formed a queue waiting for injections or vaccinations [50]. The hastiness of the procedures would 
leave little time for appropriate sterilization of syringes and catheters [18] and, accordingly, SIV/HIV 
transmissions may have occurred. However, in such procedures an infected index patient would have 
been able to transmit the virus to the next person in the row (the first one exposed), but hardly to the 
second one, because most of his/her blood remaining in the syringe would be injected in the first 
exposed person, and very little would remain while injecting the second exposed. Thus, the probability 
of infecting additional people in the queue is likely to exhibit an exponential decline, as has been 
observed for the probability of recovering HIV-1 from syringes after successive rinses: experiments 
suggest a 55%–80% decline in this probability after the first rinsing with water [171]. Per shared 
needle, the probability of transmission is around 0.6%–1.4% for intravenous injections and 
substantially less for intramuscular injections [123,125,168]. Therefore, as a thought experiment, if all 
people in an entire country were injected once with the same unsterilized syringe, and if there 
were 100 HIV-infected people before the campaign, assuming a 1% per needle share probability of 
transmission, the campaign would hardly do more than increase the number of infections from 100 
to 101. 
What is the likelihood of parenteral outbreaks of SIV/HIV in campaigns where infected index 
patients were injected many times (as happens in IDUs and modern hospital outbreaks)? The best 




candidate environments in the region of study would be the hypnoseries (such as in Nola and Ouesso) 
where the more severe HAT patients might have been interned together and could have received more 
than the standard number of 12 injections. If an SIV-infected index case entered such a ward, the 
situation might have mimicked modern nosocomial outbreaks with the virus being able to spread 
locally, adapt to humans, and possibly initiate an epidemic in a city. This scenario could have produced 
a local outbreak, but not a massive outbreak to thousands of people [17,18,35]. 
A rural hospital/hypnoserie outbreak would be plausible if, in such a rural facility, the frequency of 
boiling or rinsing of syringes was low, and the injection intensity was much higher than the average for 
HAT (Table 2). The probability of such conditions would have been higher after the early 1930s for 
several reasons: (1) the first systematic HAT, syphilis, and yaws campaigns started in 1932 in 
southeast Cameroon, and in 1930 in the Nola sector (Table 3; Section 2.4.5); (2) before that, 
intravenous drugs such as tryparsamide were less commonly used (subcutaneous/intramuscular atoxyl 
predominated). Thus, the parenteral risks in the region of study strongly intensified after 1930–32 
(Section 2.4.5). If HIV-1 had spread intensively in rural areas by unsterile injections in the 1930s, it 
would likely have continued to do so in the 1940s and 1950s, when injection intensity was higher 
(Figure 2). One would expect the postulated thousands of people so infected [17,18,35] to have 
maintained this rural HIV-1 focus in the region for decades. However, the several serological surveys 
that were made in the area in the period 1975–1992 found zero prevalence until 1987, when HIV-1 
arrived there with the pandemic wave (reviewed in [38]). 
Whereas recent datings of the origin of HIV-1 M (corroborated by the use of two “fossil” virus 
samples from 1959 and 1960) calculated the tMRCA of HIV-1 M in the range 1900–1915, with 95% 
confidence interval 1873–1924 [27,30], it cannot be excluded that these dates may still change, for 
example if heterotachy (differing evolutionary rate between lineages [30,172]) results in 
overestimating the age of HIV-1 M [30]. In addition, previous datings [25,26] included the 1930s in 
their 95% confidence interval. Further refinement of molecular dating techniques, and the discovery of 
new HIV-1 M “fossil” viruses may increase the accuracy of tMRCA datings and, when this happens, 
all arguments will have to be revised in the light of such new findings. 
The hypothesis of HIV having adapted through a parenteral serial passage event [4,32–34] cannot 
be ruled out, given that many injections and smallpox vaccinations happened in the region of study, 
even before 1930 (Sections 2.4.2 to 2.4.4). However, this is not a unique feature of parenteral serial 
transmission, and could perhaps more easily have happened by sexual serial transmission (or by a 
combination of sexual and parenteral transmission). Since the late 1890s there were CSWs, gonococcal 
urethritis, syphilis, and possibly other GUDs in the colonial posts of the region [51,54,152] 
(Section 2.5). Sex acts involving GUD have higher HIV transmission probability than unsafe 
intravenous injections: for a female with a genital ulcer, the per-act female-to-male transmission risk 
was estimated to be 4% if the male is circumcised and 43% if he is uncircumcised [36,37], while the 
male-to-female risk was estimated to be 7% [37]; these values are substantially higher than the 
estimates of per-needle share transmission risks, which fall in the range 0.6–1.4% [123,125]. 
The most recent tMRCA calculations fit well with the time of most intense selling of firearms in the 
region (1900–1907), maximal rubber exploitation in the region (1899–1923), intense trade relations 
with Kinshasa (1899–1932), First World War (1914–1916), the period when chimpanzee hunting was 
not outlawed (pre-1930), and the period of intense GUD epidemics in Kinshasa [16]. If the tMRCA 




calculations are correct, the above factors may have been more important for HIV-1 M origin than 
unsterile injections, which had a relatively low frequency in the region before 1930–1932. 
The coincidence of the above referred factors in a short period of time, together with the high 
SIVcpz prevalence in the wild, and the local peoples’ penchant for ape hunting (Section 2.3), may 
indicate that the origin of HIV-1 M was opportunistic, more determined by the conjunction of 
favorable factors and opportunities, than by any (unknown) superiority of the local SIVcpz viruses 
over others in their a priori genetic ability to infect humans. Further biological studies are however 
needed to clarify this. We are not suggesting here that the studied region was unique, just that the 
superimposition of the three geographically patchy variables (ape SIV prevalence, ape bushmeat 
intensity, and intensity of contacts with the Stanley Pool cities) probably implied that, in the whole 
range of P.t.troglodytes, P.t.schweinfurthii, and G.g.gorilla, few hot spots with comparably high risk 
of HIV emergence existed, and that the region under study was one of such hot spots. Why epidemic 
HIV-1 arrived to Kinshasa only from that hot spot and not from others might have been a matter of 
chance. Our suggestion that local high SIVcpz prevalence (as observed by recent studies) was relevant 
to explain the location of HIV-1 M origin depends on the assumption that regional differences in 
SIVcpz prevalence did not change dramatically in the P.t.troglodytes range in the last 100 years. 
Although this assumption is not proven, it is parsimonious, and in the absence of contrary evidence, we 
consider it reasonable. 
We found no clear evidence of parenteral risk factors having played a decisive role in HIV 
adaptation and emergence, and we found that intense co-factors potentially favoring HIV heterosexual 
transmission were present in both the region of study and in the Stanley Pool cities at the likely time of 
origin. Therefore we propose an Enhanced Heterosexual Transmission Hypothesis for the origin of the 
several HIV groups: each of these viruses emerged and adapted to humans through heterosexual 
transmission enhanced by a spatial and temporal coincidence of a high intensity of factors that favor 
cross-species transmission (SIV prevalence, ape bushmeat intensity), and of the same co-factors of 
heterosexual transmission that are today observed to contribute the most to the current African 
epidemic, without the need to invoke additional factors. Since we are proposing a major role for co-
factors of heterosexual transmission, which is the overwhelmingly predominant mode of transmission 
in Africa, our hypothesis follows the principle of parsimony. Our data shows that the coincidence of 
factors existed for HIV-1 M and we hypothesize that it permitted the virus to emerge by heterosexual 
transmission. Our hypothesis predicts that similar coincidence is likely to have been a key element in 
the origin of the other epidemic HIV-1 and HIV-2 groups, as well. 
The Enhanced Heterosexual Transmission Hypothesis rests not only on patterns of sexual behavior, 
but also on other factors that influence HIV transmission by the heterosexual route. The Four Cities 
Study [173] found that differences in HIV prevalence between four African cities (including Yaoundé) 
were best explained by patterns of male circumcision (and not by patterns of sexual promiscuity). The 
Enhanced Heterosexual Transmission Hypothesis includes that the lower historical prevalence of 
circumcision in the early 20th century (compared with the current situation) in Central Africa [16] 
probably contributed to the emergence of pandemic HIV-1. Furthermore, sexual promiscuity might 
have played a stronger indirect role than today by fuelling rampant GUD epidemics, which very 
strongly facilitate the transmission of HIV but are, today, in contrast to the early 20th century, 
controlled by treatments in spite of high promiscuity. 




Our research shows how varied the risk factors present in the region of origin of HIV-1 M were, 
and how far we are from knowing the complete picture. Either sexual or parenteral serial transmission 
could have partially adapted the virus in the studied region. It could have generated a small local 
epidemic before moving to Kinshasa, or it could have been brought there by a migrant bushmeat 
handler directly. Further sampling of SIVcpz viruses from many sites within the Boumba-Ngoko-
Sangha enclosure and more migration information during the last century from its host, the 
chimpanzee, could help to establish better where the virus crossed to humans, which in turn could help 
to test the hypotheses above exposed. Refinement of MRCA dating techniques and new “fossil” 
viruses could establish more clearly whether increasing parenteral risks after 1932 were accompanied 
by a radiation and expansion of the virus. Further archival research might help to quantify trade and 
migration ties to Kinshasa, Brazzaville, and other cities, the intensity of GUDs in the region, and to 
investigate the possible role of World War I. New simulations could test competing hypotheses. What 
exactly happened at the origin of HIV-1 M and HIV-1 O is still mostly unknown. 
4. Sources Used 
In addition to the listed sources about HIV, SIV, and other retroviruses, we consulted major reviews 
about the relevant epidemics of tropical diseases and STDs discussed here (sources: 
[17,18,34,39,40,72,102,115–121]). We obtained quantitative data about diseases and their treatments 
for the whole of Cameroon, AEF, and for the districts of these countries situated in the region of 
study from: 
(1) Official colonial reports about health, or containing sections about health, and covering also 
demographic issues. (A) For AEF and Cameroon, period 1920–1960, collected in the Archives 
Nationales d’Outre-Mer (ANOM), Aix-en-Provence (France), and in the Institut de Médecine 
Tropicale du Service de Santé des Armées (IMTSSA), Marseille (France). (B) For Cameroon, we used 
also the reports from the French administration to the League of Nations [50]. (C) For Kinshasa and 
the Belgian Congo we consulted the Afrika Archief, Federale Overheidsdients—Buitenlandse Zaken, 
Buitenlandse Handel en Ontwikkelingssamenwerking (FO-BZBHO), Brussels (Belgium). 
(2) We complemented this information with articles in the main colonial and tropical medicine 
journals (Ann Méd Pharm Coloniales, Ann Hyg Méd Coloniales, Bull Soc Pathol Exotique), and 
additional articles and books on the subject. Particularly important was a series of annual articles in 
Ann Méd Pharm Coloniales, covering health data in French colonies and territories under 
administration in the period 1927–1936 [87–97]. 
We collected primary ethnographic, primatological, and other works to obtain information about 
chimpanzee and gorilla hunting in the region under study, including legislation [46–48,54–68,71,73–79]. 
For this region, these sources offer a more detailed picture than the larger set of sources we used in our 
previous literature survey (applying to Central Africa as a whole), listed in the main and 
supplementary reference lists published with our previous article [16]. We complemented these with 
additional sources about the modern bushmeat crisis and ape population decline. 




We consulted historical and anthropological sources about social, economic, demographic, and 
military issues, most of which directly cover the region under study [54–56,67–70,122,141,145,151–
153,156–158,160,162]. 
We consulted modern sources about IDUs, focusing on their needle sharing behavior, and 
prevalence of HIV-1 and HCV [125–140], and reviews of modern HIV-1 nosocomial outbreaks 
[123,124,168]. 
5. Conclusions 
In this article, we reviewed the factors that may have helped HIV-1 M to emerge from its birthplace 
in the African rainforest. The cross-species transmission from chimpanzees has been suggested to have 
taken place in southeast Cameroon or the neighboring AEF areas. Indeed, SIVcpz is far more prevalent 
in this area than in most other areas of the P.t.troglodytes and P.t.schweinfurthii range, while SIVgor 
has not been found there. The conjunction of favorable conditions in a short period of time—ape 
bushmeat hunting intensification, social disruption, nascent cities with commercial sex workers and 
STDs (including genital ulcer diseases)—seem to have coincided with tMRCA estimates for HIV-1 M, 
suggesting that the origin of the epidemic was opportunistic, probably more associated with these 
conditions than with a potential predisposition of local SIVcpz over other SIVcpz to infect humans. 
While the parenteral hypothesis of HIV origins still deserves further verification through modeling, 
we already see two major difficulties. First, the injection treatments in the region intensified sharply 
only in 1930–1932, while the upper confidence intervals of most recently published tMRCA 
calculations fall before that. Second, local syphilis, yaws, and HAT patients received far fewer 
injections per year than current IDUs and patients in hospital outbreaks for which good records were 
kept. Therefore, the strongest version of the parenteral theories, that proposing massive parenteral 
spread of HIV-1 to thousands of people in rural areas, seems unlikely. A more limited local parenteral 
outbreak of HIV-1 could have occurred in hypnoseries or other health facilities where injection 
intensity was higher than average, especially after 1932. The hypothesis of HIV-1 adaptation by serial 
passage involving a short chain of transmissions is plausible and could have happened at any time 
during colonial domination of the region. This mechanism could have happened by either parenteral or 
sexual transmission.  
We therefore propose an Enhanced Heterosexual Transmission Hypothesis for the origin of HIV-1 
M, by which the emergence of the virus was caused by a coincidence of high intensity of favorable 
factors for cross-species transmission (SIV prevalence and ape bushmeat hunting), and of factors that 
are today associated with HIV heterosexual spread in Africa (travel/migration, social disruption, sex 
work, STDs, GUDs, and possibly lack of male circumcision). While there is no necessity for parenteral 
transmission in this hypothesis, it does not exclude a role for it in the initial adaptation of SIVcpz 
to humans. 
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